Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
754 grants for Others
Sorted by deadline (soonest first)
U.S. National Science Foundation State and Regional Artificial Intelligence Infrastructure Hubs:
NSF · 26-513
Closes Nov 4, 2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-255
Closes Nov 5, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-095
Closes Nov 6, 2026
Fiscal Year (FY) 2027 Department of War (DoW) Defense University Research Instrumentation Program (DURIP)
DOD-ONR · N0001426SF003
Closes Nov 6, 2026
Fiscal Year (FY) 2027 Department of War (DoW) Defense University Research Instrumentation Program (DURIP)
DOD-AMC · W911NF26S0095
Closes Nov 6, 2026
ROSES25: A.15 Biosphere
NASA-HQ · NNH25ZDA001N-BIOS
Closes Nov 6, 2026
Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319
EPA · EPA-OW-OWOW-26-01
Closes Nov 9, 2026
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
HHS-NIH11 · RFA-NS-26-001
Closes Nov 10, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-002
Closes Nov 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-001
Closes Nov 10, 2026
ROSES25: C.4 Planetary Science Enabling Facilities
NASA-HQ · NNH25ZDA001N-PSEF
Closes Nov 10, 2026
Capacity Building Grants for Non-Land-Grant Colleges of Agriculture Program
USDA-NIFA · USDA-NIFA-NLGCA-011938
Closes Nov 10, 2026
ROSES 2025: C.2 Solar System Science
NASA-HQ · NNH25ZDA001N-SCUBED
Closes Nov 12, 2026
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-271
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-269
Closes Nov 13, 2026
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
HHS-NIH11 · PAR-24-089
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-270
Closes Nov 13, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
HHS-NIH11 · PAR-25-370
Closes Nov 16, 2026
Major Research Instrumentation Program
NSF · 23-519
Closes Nov 16, 2026
Special Program Announcement for Office of Naval Research Research Opportunity: FY27 Communications and Networking Applied Research
DOD-ONR · N0001426SBC11
Closes Nov 16, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
HHS-NIH11 · PAR-25-274
Closes Nov 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-268
Closes Nov 17, 2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-267
Closes Nov 17, 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11 · PAR-25-158
Closes Nov 17, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Closes Nov 17, 2026